Filter By Industry
Filter By Tag


Huateng Pharma Press releases

31 - 36 of 36 Press Releases

Sep 17, 2020
LAROTRECTINIB APPROVED FOR SOLID TUMORS WITH NTRK MUTATION On November 26, 2018,FDA approved larotrectinib (Vitrakvi; Loxo Oncology), the first drug approved for the treatment of adults and pediatric patients with solid tumors that have an NTRK gene...

Aug 18, 2020
This is a remarkable, massive, multinational study that has provided insights that can inform patient choices about hypertension treatment.

Jul 16, 2020
A single dose of the flu drug baloxavir marboxil can reduce the spread of the illness within households, new research concludes.

Jun 16, 2020
What's the boronic acid? A boronic acid is a compound related to boric acid in which one of the three hydroxyl groups is replaced by an alkyl or aryl group.

May 20, 2020
Carfilzomib (marketed under the trade name Kyprolis, developed by Onyx Pharmaceuticals) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin.

Apr 23, 2020
The 2019 novel coronavirus (COVID-19) has spread rapidly since its recent identification in patients with severe pneumonia in Wuhan, China. The pandemic has spread to over 150 countries and territories.

Page: Prev 1 2 3 4
Huateng Pharma RSS Feed